| CRNX Stock | | | USD 56.77 0.68 1.21% |
Crinetics Pharmaceuticals financial indicator trend analysis is way more than just evaluating Crinetics Pharmaceuticals prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Crinetics Pharmaceuticals is a good investment. Please check the relationship between Crinetics Pharmaceuticals Accounts Payable and its Net Tangible Assets accounts. Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in Crinetics Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in board of governors.
For more information on how to buy Crinetics Stock please use our
How to Invest in Crinetics Pharmaceuticals guide.
Accounts Payable vs Net Tangible Assets
Accounts Payable vs Net Tangible Assets Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Crinetics Pharmaceuticals Accounts Payable account and
Net Tangible Assets. At this time, the significance of the direction appears to have very strong relationship.
The correlation between Crinetics Pharmaceuticals' Accounts Payable and Net Tangible Assets is 0.84. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Net Tangible Assets in the same time period over historical financial statements of Crinetics Pharmaceuticals, assuming nothing else is changed. The correlation between historical values of Crinetics Pharmaceuticals' Accounts Payable and Net Tangible Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of Crinetics Pharmaceuticals are associated (or correlated) with its Net Tangible Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Tangible Assets has no effect on the direction of Accounts Payable i.e., Crinetics Pharmaceuticals' Accounts Payable and Net Tangible Assets go up and down completely randomly.
Correlation Coefficient | 0.84 |
| Relationship Direction | Positive |
| Relationship Strength | Strong |
Accounts Payable
An accounting item on the balance sheet that represents Crinetics Pharmaceuticals obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Crinetics Pharmaceuticals are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.
Net Tangible Assets
The total assets of a company minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company.
Most indicators from Crinetics Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Crinetics Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in Crinetics Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in board of governors.
For more information on how to buy Crinetics Stock please use our
How to Invest in Crinetics Pharmaceuticals guide.
Selling General Administrative is likely to rise to about 61
M in 2024, whereas
Issuance Of Capital Stock is likely to drop slightly above 188.1
M in 2024.
Crinetics Pharmaceuticals fundamental ratios Correlations
Click cells to compare fundamentals
Crinetics Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Crinetics Pharmaceuticals fundamental ratios Accounts
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for Crinetics Stock Analysis
When running Crinetics Pharmaceuticals' price analysis, check to
measure Crinetics Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Crinetics Pharmaceuticals is operating at the current time. Most of Crinetics Pharmaceuticals' value examination focuses on studying past and present price action to
predict the probability of Crinetics Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Crinetics Pharmaceuticals' price. Additionally, you may evaluate how the addition of Crinetics Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.